SIGA Rated Strong Buy as STW Biotech Stock of the Week

Online, June 21, 2010 (Newswire.com) - Stock market traders and investors benefit from the research and experience of the analysts who have been successfully trading small cap stocks in the biotech sector for several years. Day traders, swing traders and investors should do their own due diligence before taking a position in SIGA.

The STW swing trading tip of the week is SIGA an emerging biotech stock they have followed for several years. STW believes SIGA is close to finalizing a large contract with the US Government BARDA agency for the purchase of ST-246 and smallpox antiviral for the strategic national stockpile. Siga also has a promising pipeline of other drugs in development.

For specific details about SIGA Stock visit www.stocktipweekly.com

ABOUT
The stock analysts at STW isolate emerging & small cap stocks focusing on the biotech and pharmaceutical sectors. Each week they feature one stock recommendation that analysis shows has good upside potential for a swing trade or long term profits. The STW Stock Picks are chosen on several factors including current company news, FDA trials technical analysis and general market trends to help traders and investors select the best share price entry and timing.